Animal cognitionAnimal cognition encompasses the mental capacities of non-human animals including insect cognition. The study of animal conditioning and learning used in this field was developed from comparative psychology. It has also been strongly influenced by research in ethology, behavioral ecology, and evolutionary psychology; the alternative name cognitive ethology is sometimes used. Many behaviors associated with the term animal intelligence are also subsumed within animal cognition.
Animal languageAnimal languages are forms of non-human animal communication that show similarities to human language. Animals communicate through a variety of signs, such as sounds or movements. Signing among animals may be considered complex enough to be a form of language if the inventory of signs is large. The signs are relatively arbitrary, and the animals seem to produce them with a degree of volition (as opposed to relatively automatic conditioned behaviors or unconditioned instincts, usually including facial expressions).
Olney's lesionsOlney's lesions, also known as NMDA receptor antagonist neurotoxicity (NAT), is a form of brain damage observed in rats and certain other model animals exposed to large quantities of psychoactive drugs that inhibit the normal operation of the neuronal NMDA receptor. Such lesions are common in anesthesia, as well as certain psychiatric treatments. The visible signs of NAT are named after John Olney, who conducted a study in 1989 to investigate neurotoxicity caused by PCP and related drugs.
Human–animal communicationHuman–animal communication is the communication observed between humans and other animals, ranging from non-verbal cues and vocalizations to the use of language. Some human–animal communication may be observed in casual circumstances, such as the interactions between pets and their owners, which can reflect a form of spoken, while not necessarily verbal dialogue. A dog being scolded is able to grasp the message by interpreting cues such as the owner's stance, tone of voice, and body language.
AtomoxetineAtomoxetine, sold under the brand name Strattera, among others, is a medication used to treat attention deficit hyperactivity disorder (ADHD). It may be used alone or along with psychostimulants. It is also used as a cognitive enhancer to improve alertness, attention, and memory. Use of atomoxetine is only recommended for those who are at least six years old. It is taken orally. Atomoxetine is a norepinephrine reuptake inhibitor and is believed to work by increasing norepinephrine and dopamine levels in the brain.
